Search Results 811-820 of 17553 for Assay

  1. Brain Lymphoma Clinical Trials - Mayo Clinic Research

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR) Rochester, MN. The purpose of this ...

  2. Kidney Tumor Clinical Trials - Mayo Clinic Research

    Cohort 1 includes blood collections for in vitro studies which are a component of NIH-funded Project 3 within the Mayo Clinic ... cfDNA Assay Prospective ...

  3. A Study To Learn About The Effects Of Felzartamab Infusions In Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation - Mayo Clinic

    ... assays within 3 months prior to randomization. Key Exclusion Criteria: * Transplant: Blood type (ABO)-incompatible transplant. * History of multiple organ ...

  4. A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma - Mayo Clinic

    ... assay 5. Barcelona Clinic Liver Cancer Stage B (if not amenable to local treatment/surgery) or C prior to apheresis 6. Child-Pugh score: Grade A 7 ...

  5. A Study of KRN23 in Adult Subjects with Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome - Mayo Clinic

    Have an FGF23 level ≥ 100 pg/mL by Kainos assay. Have a ratio of renal tubular maximum reabsorption rate of phosphate to glomerular filtration rate (TmP ...

  6. Alkaline phosphatase (ALP) blood test - Mayo Clinic

    An ALP blood test checks the health of your liver, bones and other body areas. Learn when the test is done, how to prepare and what the results mean.

  7. Type 1 Diabetes Clinical Trials - Mayo Clinic Research

    ... assay that would detect antibodies to insulin and insulin analogs. Butyrate Adjuvant Therapy for Type 1 Diabetes Rochester, MN. This study will test the ...

  8. Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD) - Mayo Clinic

    Indeterminate Quantiferon gold assays must be repeated(with same or other interferon gamma release assay (IGRA) per local policy) and shown to be negative.

  9. A Study of the Effect of Dalcetrapib on Cardiovascular Risk for a Genetically Defined Population who have had a Recent Acute Coronary Syndrome Event - Mayo Clinic

    AA genotype at variant gene as determined by Genotype Assay testing, conducted at a designated investigational testing site (ITS); Clinically stable, ie ...

  10. Focus areas - Cellular Mechanisms of Neurodegenerative Disorders: Fabienne C. Fiesel - Mayo Clinic Research

    Fiesel's team use genetic models to advance the mechanistic understanding of this pathway. The team develops biomarker assays and small molecule compounds. This ...